NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

417 hedge funds and large institutions have $9.23B invested in Neurocrine Biosciences in 2021 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 160 increasing their positions, 126 reducing their positions, and 60 closing their positions.

Holders
417
Holders Change
+14
Holders Change %
+3.47%
% of All Funds
7.34%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
77
Increased
160
Reduced
126
Closed
60
Calls
$69.4M
Puts
$52.1M
Net Calls
+$17.2M
Net Calls Change
+$93.8M

Top Buyers

1
BlackRock
1
BlackRock
New York
$1.07B
2
PHS
2
PFM Health Sciences
California
$103M
3
State Street
3
State Street
Massachusetts
$318M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$188M
5
DM
5
Deerfield Management
New York
$70.5M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$153M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$691M
3
PA
3
Perceptive Advisors
New York
$91.6M
4
RSCM
4
Rock Springs Capital Management
Maryland
$98.7M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$561M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$1.07B 10,989,474 +3,991,679 +57%
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$898M 9,231,289 +70,148 +0.8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$859M 8,829,275 +492,010 +6%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$691M 7,102,088 -1,254,990 -15%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$561M 5,773,359 -498,371 -8%
BG
6
Bellevue Group
Switzerland
$318M 3,274,551 -122,100 -4%
State Street
7
State Street
Massachusetts
$318M 3,267,343 +790,012 +32%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$188M 1,932,147 +760,465 +65%
Capital International Investors
9
Capital International Investors
California
$153M 1,572,326 -1,840,323 -54%
PAMU
10
Pictet Asset Management (UK)
United Kingdom
$152M 1,562,523 -134,467 -8%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$149M 1,535,811 +582,548 +61%
Goldman Sachs
12
Goldman Sachs
New York
$137M 1,407,474 +189,709 +16%
Renaissance Technologies
13
Renaissance Technologies
New York
$136M 1,397,864 -409,327 -23%
DCP
14
DSM Capital Partners
Florida
$131M 1,348,507 +232,127 +21%
O
15
OrbiMed
New York
$127M 1,301,715 – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$115M 1,179,508 +53,898 +5%
Citadel Advisors
17
Citadel Advisors
Florida
$110M 1,135,347 -12,160 -1%
Invesco
18
Invesco
Georgia
$106M 1,087,365 +4,224 +0.4%
PHS
19
PFM Health Sciences
California
$103M 1,055,510 +1,055,510 New
RSCM
20
Rock Springs Capital Management
Maryland
$98.7M 1,015,000 -560,000 -36%
Northern Trust
21
Northern Trust
Illinois
$93.5M 961,003 +327,101 +52%
PA
22
Perceptive Advisors
New York
$91.6M 941,832 -957,383 -50%
Franklin Resources
23
Franklin Resources
California
$88M 904,854 +9,984 +1%
CAM
24
Congress Asset Management
Massachusetts
$87.7M 901,834 +140,893 +19%
EVM
25
Eaton Vance Management
Massachusetts
$79.4M 816,416 +287,927 +54%
1
2 3 4 5